USPTO serial 98656792
AVENAT
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- GORAN, BRADLEY TAYLOR
- Law office
- TMEG LAW OFFICE 107
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AVENAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki, Esq.
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP600 Peachtree Street, NE, Suite 3000c/o TM DKT CLKAtlanta, GA 30308Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients in the nature of avenanthramides and oat beta glucan for use in the manufacture of cosmeceuticals, nutraceuticals, and pharmaceuticals | ACTIVE | — |
| 005 | (Based on 44(e))(Based on Intent To Use) Dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides for the treatment and prevention of inflammation, inflammatory bowel syndrome, joint inflammation, atherosclerosis, and cancer; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan for modulating glucose metabolism, for preventing and treating metabolic diseases and disorders, and for lowering cholesterol; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering for the treatment of immune-based diseases and disorders of the immune system, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to animal fodder in the nature of dietary supplements for medical purposes; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements; medicinal oils, other than essential oils (Based on Intent To Use) medicated skin care preparations, namely, creams, lotions, and gels; medicated skin care preparations, namely, creams, lotions and gels containing oat beta glucan; bandages for skin wounds; medicated bandages for dressings; bandages impregnated with oat beta glucan for medicinal purposes | ACTIVE | — |
| 030 | Bread; flour and preparations made from cereals, namely, cereal bars, cereal-based snacks, and breakfast cereals; oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, and noodles | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 26, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 26, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 26, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 4, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2026 | ALIE | ASSIGNED TO LIE | — |
| Jun 2, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 30, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 30, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 30, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 30, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 2, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 19, 2024 | NWAP | NEW APPLICATION ENTERED | — |